Cervical Paraspinal Muscle Twitching and Cervical Facet Radiofrequency Ablation Outcomes
Launched by JOHNS HOPKINS UNIVERSITY · Jul 5, 2022
Trial Information
Current as of July 09, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new way to predict how well a treatment called cervical radiofrequency ablation (RFA) will work for people suffering from neck pain caused by cervical facet joint issues. The researchers want to find out if certain muscle twitches that happen during the procedure can indicate whether the treatment will be successful. They will use a simple scoring system to track these twitches, which could help doctors understand how effective the treatment might be for pain relief.
To take part in this trial, participants must be at least 18 years old and have a history of neck pain for more than three months, along with some specific signs that a doctor can identify. They should have experienced at least some pain relief from a previous diagnostic procedure targeting the same nerves. Participants can expect to undergo the RFA procedure, where their muscle activity will be monitored, and they will be closely observed for pain relief after the treatment. It's important to know that people with certain medical conditions or who are pregnant will not be eligible for this study.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age 18 years or older
- • Cervical facet arthropathy based on history and physical exam (e.g. axial cervical neck pain, paraspinal tenderness, no pain referral below the ipsilateral shoulder)
- • Radiologic evidence of cervical pathology consistent with symptoms if MRI is available
- • Pain duration of greater than 3 months
- • Obtained 50% or greater pain relief from at least 1 diagnostic cervical medial branch block of the identical medial branch nerves targeted for RFA
- Exclusion Criteria:
- • Untreated coagulopathy
- • Signs or symptoms of cervical myelopathy
- • Signs or symptoms of cervical radiculitis/radiculopathy
- • Allergic reactions to local anesthetics
- • Serious psychiatric disorder (e.g. uncontrolled or refractory depression) that might preclude optimal outcome
- • Poorly controlled medical condition (e.g. pacemaker that cannot be switched off, unstable angina)
- • Pregnancy
About Johns Hopkins University
Johns Hopkins University, a prestigious research institution located in Baltimore, Maryland, is renowned for its commitment to advancing medical science and public health through innovative clinical trials. With a rich history of groundbreaking research and a multidisciplinary approach, the university's clinical trial initiatives focus on translating scientific discoveries into effective treatments and interventions. Leveraging state-of-the-art facilities and a collaborative network of experts, Johns Hopkins University conducts rigorous clinical studies that aim to improve patient outcomes and address critical health challenges. Its dedication to ethical standards and participant safety underscores its role as a leader in clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Baltimore, Maryland, United States
Patients applied
Trial Officials
Eric Wang, MD
Principal Investigator
Johns Hopkins University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials